8-K: Doximity Announces Strong Q4 and Fiscal Year 2025 Financial Results, Revenue Up 20%
Earnings Release
Doximity reports a successful fiscal year 2025 with a 20% increase in total revenue and significant growth in operating and free cash flow.
Summary
- Doximity announced its financial results for the fourth quarter and fiscal year ended March 31, 2025.
- Q4 total revenues reached $138.3 million, a 17% increase year-over-year.
- Q4 operating cash flow was $98.5 million, up 54% year-over-year, and free cash flow was $97.0 million, up 56% year-over-year.
- Fiscal year 2025 total revenues amounted to $570.4 million, a 20% increase year-over-year.
- Fiscal year 2025 operating cash flow was $273.3 million, up 48% year-over-year, and free cash flow was $266.7 million, up 50% year-over-year.
- Net income for the fiscal year was $223.2 million, compared to $147.6 million in the previous year.
- Adjusted EBITDA for the fiscal year was $313.8 million, up 36% year-over-year.
- The company is providing revenue guidance of $139 million to $140 million and adjusted EBITDA between $71 million and $72 million for the first quarter ending June 30, 2025.
- For the fiscal year ending March 31, 2026, Doximity expects revenue between $619 million and $631 million and adjusted EBITDA between $333 million and $345 million.
Sentiment
Score: 9
Explanation: The document presents a highly positive outlook with strong financial results and optimistic future guidance, indicating a very favorable sentiment.
Positives
- Doximity experienced strong revenue growth in both Q4 and fiscal year 2025.
- The company's operating and free cash flow saw substantial increases year-over-year.
- Doximity's net income and adjusted EBITDA margins improved significantly.
- The company's subscription revenue increased by 17% in Q4 and 21% for the full fiscal year.
- Doximity is providing positive revenue and adjusted EBITDA guidance for fiscal year 2026.
Risks
- The forward-looking statements are subject to various risks and factors, including economic uncertainty, ability to retain and attract members and customers, security breaches, and competitive pressures.
- The company's future performance could be affected by the risks outlined in their Form 10-Q and Form 10-K filings.
Future Outlook
Doximity expects revenue between $139 million and $140 million and adjusted EBITDA between $71 million and $72 million for the first quarter ending June 30, 2025. For the fiscal year ending March 31, 2026, the company anticipates revenue between $619 million and $631 million and adjusted EBITDA between $333 million and $345 million.
Management Comments
- Jeff Tangney, co-founder and CEO of Doximity, stated that they closed out fiscal 2025 on a high note, with record engagement, strong profits, and 20% annual revenue growth.
- Tangney noted that their newsfeed, workflow, and AI tools all hit fresh highs in Q4, helping doctors save time and provide the best care for their patients.
Industry Context
Doximity's strong financial results reflect the increasing adoption of digital platforms in the healthcare industry. The company's focus on providing tools for medical professionals aligns with the growing need for efficient communication, information access, and virtual care solutions.
Comparison to Industry Standards
- Doximity's revenue growth of 20% year-over-year is strong compared to other healthcare technology companies.
- Teladoc Health, another player in the telehealth space, has seen fluctuating growth rates in recent years, making Doximity's consistent growth notable.
- Companies like Veeva Systems, which provide cloud-based solutions for the life sciences industry, also serve as benchmarks for growth and profitability in the healthcare technology sector.
- Doximity's adjusted EBITDA margin of 55.0% for fiscal year 2025 indicates strong profitability compared to industry averages.
Stakeholder Impact
- Shareholders will likely react positively to the strong financial results and optimistic guidance.
- Employees may benefit from the company's continued growth and profitability.
- Customers (medical professionals) can expect continued investment in the platform's features and capabilities.
Next Steps
- Doximity will host a webcast to discuss these financial results.
- The company will release its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.
Key Dates
| Date | Description |
|---|---|
| 2010 | Doximity was founded. |
| December 31, 2024 | Date of the fiscal quarter ended for the Quarterly Report on Form 10-Q referenced in the forward-looking statements. |
| March 31, 2025 | End of fiscal year 2025 and fourth quarter. |
| May 15, 2025 | Date of the press release announcing financial results. |
| June 30, 2025 | End of the first quarter of fiscal year 2026, for which revenue and adjusted EBITDA guidance is provided. |
| March 31, 2026 | End of fiscal year 2026, for which revenue and adjusted EBITDA guidance is provided. |
Keywords
Doximity, financial results, revenue, EBITDA, cash flow, healthcare, digital platform, medical professionals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.